Driven by broader market demand and more profits, it has become a general trend for enterprises to make medical devices going overseas. From the perspective of profitability, pricing in markets of developed countries is higher, leaving a higher profit margin for products of the same type to be sold overseas. Meanwhile, the competition among innovative enterprises in domestic market is extremely fierce, while in overseas market, the unit price of innovative items shows a trend of gradual increase along with the iterative updating of products by heading enterprises, and the market is huge in size and lucrative in profit.

When it comes to policy, the overseas market supervision system is well-established, but the requirements for supervisory regulations on the launching of medical devices vary in different countries and regions. Market certification in these developed countries is difficult, but correspondingly, the competitive landscape for launched medical device products is favorable due to high barriers set to join the game.

This conference will invite the heads of overseas chambers of commerce/consulates/associations to share their experience of going overseas and the local policies and regulations of the market pattern for the attending audience. It will help the global layout of medical upstream and downstream supply chain enterprises.